ES8303091A1 - Un procedimiento para la preparacion de una nueva formulacion de bacampicilina. - Google Patents

Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.

Info

Publication number
ES8303091A1
ES8303091A1 ES504905A ES504905A ES8303091A1 ES 8303091 A1 ES8303091 A1 ES 8303091A1 ES 504905 A ES504905 A ES 504905A ES 504905 A ES504905 A ES 504905A ES 8303091 A1 ES8303091 A1 ES 8303091A1
Authority
ES
Spain
Prior art keywords
suspension
acid addition
addition salt
oral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES504905A
Other languages
English (en)
Spanish (es)
Other versions
ES504905A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of ES504905A0 publication Critical patent/ES504905A0/es
Publication of ES8303091A1 publication Critical patent/ES8303091A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ES504905A 1980-08-22 1981-08-21 Un procedimiento para la preparacion de una nueva formulacion de bacampicilina. Expired ES8303091A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/180,537 US4321253A (en) 1980-08-22 1980-08-22 Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration

Publications (2)

Publication Number Publication Date
ES504905A0 ES504905A0 (es) 1983-02-01
ES8303091A1 true ES8303091A1 (es) 1983-02-01

Family

ID=22660812

Family Applications (1)

Application Number Title Priority Date Filing Date
ES504905A Expired ES8303091A1 (es) 1980-08-22 1981-08-21 Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.

Country Status (41)

Country Link
US (1) US4321253A (enExample)
JP (1) JPS5775986A (enExample)
KR (1) KR860000513B1 (enExample)
AR (1) AR227201A1 (enExample)
AT (1) AT370994B (enExample)
AU (1) AU529965B2 (enExample)
BE (1) BE890028A (enExample)
BG (1) BG42000A3 (enExample)
CA (1) CA1137414A (enExample)
CH (1) CH650674A5 (enExample)
CS (1) CS225845B2 (enExample)
DD (1) DD201644A5 (enExample)
DE (1) DE3132614C2 (enExample)
DK (1) DK158971C (enExample)
DZ (1) DZ315A1 (enExample)
ES (1) ES8303091A1 (enExample)
FI (1) FI72647C (enExample)
FR (1) FR2488798A1 (enExample)
GB (1) GB2082539B (enExample)
GR (1) GR74983B (enExample)
HK (1) HK43786A (enExample)
HU (1) HU188679B (enExample)
IE (1) IE51506B1 (enExample)
IL (1) IL63617A (enExample)
IN (1) IN156538B (enExample)
IT (1) IT1138161B (enExample)
KE (1) KE3626A (enExample)
LU (1) LU83572A1 (enExample)
MX (1) MX5731A (enExample)
MY (1) MY8600597A (enExample)
NL (1) NL191978C (enExample)
NO (1) NO154821C (enExample)
NZ (1) NZ198106A (enExample)
PH (1) PH17125A (enExample)
PL (1) PL232141A1 (enExample)
PT (1) PT73555B (enExample)
RO (1) RO82679B (enExample)
SE (1) SE448819B (enExample)
SU (1) SU1364226A3 (enExample)
YU (1) YU43985B (enExample)
ZA (1) ZA815793B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950977A1 (de) * 1978-12-22 1980-07-10 Donald E Panoz Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
EP0111560A4 (en) * 1982-06-14 1987-02-03 Key Pharma Sustained release aspirin.
WO1984000295A1 (en) * 1982-07-09 1984-02-02 Key Pharma Sustained release quinidine dosage form
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
EP0642344B1 (en) * 1992-04-30 1997-03-19 Schering Corporation Stable hydrated cephalosporin dry powder for oral suspension formulation
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
IN191482B (enExample) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
JP4711478B2 (ja) * 1999-08-13 2011-06-29 旭化成ケミカルズ株式会社 味がマスクされた薬物
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
HUP0204372A3 (en) 1999-12-23 2004-06-28 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
PT1276470E (pt) 2000-04-20 2007-08-13 Novartis Ag Composição de revestimento para dissimular o sabor
WO2001093835A1 (en) * 2000-06-02 2001-12-13 Zycos Inc. Delivery systems for bioactive agents
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
JP2004532257A (ja) * 2001-05-31 2004-10-21 シーマ・ラブス、インコーポレイテッド 高水溶性薬剤のテイスト・マスキング
KR20030015655A (ko) * 2001-08-17 2003-02-25 한미약품공업 주식회사 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
JP4698950B2 (ja) * 2002-04-09 2011-06-08 フラメル・テクノロジー アモキシシリンの改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
US20180177820A1 (en) * 2015-10-13 2018-06-28 Techno Guard Co. Ltd. Protective composition for gastrointestinal mucosa

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
ZA718014B (en) 1970-12-23 1972-08-30 Beecham Group Ltd Pharmaceutical formulations
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
GB1479655A (en) 1974-03-08 1977-07-13 Beecham Group Ltd Antibiotic preparations
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
ZA793934B (en) * 1978-08-04 1980-07-30 Beecham Group Ltd Powders
JPS57105316A (en) * 1980-12-23 1982-06-30 Hitachi Cable Ltd Method of fitting heat-shrinkable tube

Also Published As

Publication number Publication date
IE51506B1 (en) 1987-01-07
FI72647B (fi) 1987-03-31
HU188679B (en) 1986-05-28
IT8123587A0 (it) 1981-08-20
CA1137414A (en) 1982-12-14
CH650674A5 (fr) 1985-08-15
ES504905A0 (es) 1983-02-01
PH17125A (en) 1984-06-01
CS225845B2 (en) 1984-02-13
BG42000A3 (en) 1987-09-15
LU83572A1 (fr) 1982-04-14
SE448819B (sv) 1987-03-23
RO82679A (ro) 1984-05-23
JPH0248525B2 (enExample) 1990-10-25
IT1138161B (it) 1986-09-17
NL8103902A (nl) 1982-03-16
IL63617A (en) 1984-11-30
NL191978B (nl) 1996-08-01
JPS5775986A (en) 1982-05-12
YU43985B (en) 1990-02-28
NL191978C (nl) 1996-12-03
US4321253A (en) 1982-03-23
GB2082539B (en) 1984-01-18
FR2488798A1 (fr) 1982-02-26
PL232141A1 (enExample) 1982-03-15
IE811911L (en) 1982-02-22
DK372181A (da) 1982-02-23
DE3132614C2 (de) 1985-08-22
ATA362781A (de) 1982-10-15
PT73555A (en) 1981-09-01
KR860000513B1 (ko) 1986-05-02
FR2488798B1 (enExample) 1985-01-11
AU7441681A (en) 1982-04-01
DK158971B (da) 1990-08-13
KR830005850A (ko) 1983-09-14
HK43786A (en) 1986-06-20
FI812574L (fi) 1982-02-23
RO82679B (ro) 1984-07-30
KE3626A (en) 1986-05-16
MX5731A (es) 1993-11-01
SE8104974L (sv) 1982-02-23
BE890028A (fr) 1982-02-22
GB2082539A (en) 1982-03-10
NO154821B (no) 1986-09-22
FI72647C (fi) 1987-07-10
MY8600597A (en) 1986-12-31
YU201781A (en) 1984-04-30
DE3132614A1 (de) 1982-05-19
NO812827L (no) 1982-02-23
PT73555B (en) 1983-07-14
AT370994B (de) 1983-05-25
IN156538B (enExample) 1985-08-31
GR74983B (enExample) 1984-07-12
DD201644A5 (de) 1983-08-03
SU1364226A3 (ru) 1987-12-30
AR227201A1 (es) 1982-09-30
AU529965B2 (en) 1983-06-30
NO154821C (no) 1987-01-07
NZ198106A (en) 1983-12-16
IL63617A0 (en) 1981-11-30
DK158971C (da) 1991-01-07
DZ315A1 (fr) 2004-09-13
ZA815793B (en) 1982-08-25

Similar Documents

Publication Publication Date Title
ES8303091A1 (es) Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
KR900013952A (ko) 경구투여용 이부프로펜 조성물
HRP20010243B1 (hr) Pripravci koji sadrže difosfonske kiseline
AR022930A2 (es) MICROCAPSULAS, DE TIPO RESERVORIO, QUE CONTIENEN POR LO MENOS UN PRINCIPIO ACTIVO MEDICAMENTOSO Y/O NUTRITIVO (PA) CON EXCLUSION DEL ACIDO ACETILSALICILICO (ASA), DESTINADAS A LA ADMINISTRACION POR VIA ORAL, SU UTILIZACIoN Y FORMA FARMACEUTICA QUE COMPRENDE A DICHAS MICROCAPSULAS.
CO5210868A1 (es) Composiciones que tienen estabilidad mejorada
DK0533865T3 (da) Bioaktivt tørderivat og farmaceutiske og kosmetiske præparater med indhold deraf
NZ501950A (en) Medicinal compositions for application to mucosa
ES2171440T3 (es) Composicion solida mucoadhesiva, terapeutica o higienica, para administracion por aplicacion sobre la mucosa bucal o nasal.
JP2002020253A (ja) 口腔用組成物
ES2099649T3 (es) Nueva composicion farmaceutica destinada para la fabricacion de un polvo estable que contiene, a titulo de ingrediente activo, una asociacion de acido acetilsalicilico y de metoclopramida.
BRPI0513640B1 (pt) Composição de creme dental opaca e seu método de fabricação
RU2412688C2 (ru) Стабилизированная кислород-выделяющая композиция
YU86792A (sh) Rastvor sparfloksacina, njegovo dobijanje i so sparfloksacina kao komponenta rastvora
JPS5441320A (en) Slow release preparation and its manufacturing
AR043536A1 (es) Composicion farmaceutica que comprende acido 5-metil-2-(2´-cloro-6´-fluoroanilino)fenilacetico
JPS57146722A (en) Pharmaceutical preparation having improved absorption
RU2524631C2 (ru) Изменение цвета содеращих халкон препаративных форм по уходу за ротовой полостью
ES2533624T3 (es) Composición para prevenir y tratar patologías odontoestomatológicas de los animales
JP2001079568A (ja) 脱塩素剤
JPS62126130A (ja) 動物用医薬組成物
JPS6056683B2 (ja) 安定化されたカルプロニウムクロライド配合剤
JPS57118509A (en) Novel preparation of high absorbability
DK595987A (da) Osmotisk kontinuerligt dispenserende oralt afgivelsessystem indeholdende et moderat vandoploeseligt metoprololsalt
GB2285923A (en) Pharmaceutical powder containing N-acetyl-cysteine

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20100623